Afana Hatem B, Ashokan Shine, Nau Thomas
Orthopaedic Department, King's College Hospital London Dubai, Dubai Hills, Alkhail Road, Marabea' East Exit, PO Box No 340901, Dubai, United Arab Emirates.
Orthopaedic Department, King's College Hospital London Dubai, Dubai Hills, Alkhail Road, Marabea' East Exit, PO Box No 340901, Dubai, United Arab Emirates - Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, PO Box 505055, Dubai United Arab Emirates.
SICOT J. 2025;11:38. doi: 10.1051/sicotj/2025032. Epub 2025 Jul 16.
Venous thromboembolism (VTE) is a rare but potentially serious complication following anterior cruciate ligament reconstruction (ACLR). There is no guideline for the routine use of anticoagulants post-ACLR surgery.
This retrospective case-control study reviewed 199 patients who underwent ACLR between February 2020 and November 2024. Two groups were compared: Group A (n = 113) received no pharmacological prophylaxis, while Group B (n = 86) received low-molecular-weight heparin (LMWH) for 2 weeks postoperatively. The incidence of symptomatic VTE, postoperative bleeding, and related complications was evaluated.
No symptomatic VTE or bleeding complications were observed in either group. There was no statistically significant difference between the groups in terms of age, BMI, smoking, comorbidities, and postoperative weight bearing. There was a significant difference in surgical duration, graft type, and meniscal procedure.
Our findings support a risk-stratified approach rather than universal pharmacologic prophylaxis in ACLR patients.
静脉血栓栓塞症（VTE）是前交叉韧带重建术（ACLR）后一种罕见但可能严重的并发症。目前尚无ACLR术后常规使用抗凝剂的指南。
这项回顾性病例对照研究纳入了2020年2月至2024年11月期间接受ACLR的199例患者。比较了两组：A组（n = 113）未接受药物预防，而B组（n = 86）术后接受低分子量肝素（LMWH）治疗2周。评估了有症状VTE、术后出血及相关并发症的发生率。
两组均未观察到有症状的VTE或出血并发症。两组在年龄、体重指数、吸烟、合并症及术后负重方面无统计学显著差异。手术时间、移植物类型和半月板手术存在显著差异。
我们的研究结果支持对ACLR患者采用风险分层方法，而非普遍进行药物预防。
